Page last updated: 2024-10-19

thioctic acid and Dry Macular Degeneration

thioctic acid has been researched along with Dry Macular Degeneration in 1 studies

Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kim, BJ1
Hunter, A1
Brucker, AJ1
Hahn, P1
Gehrs, K1
Patel, A1
Edwards, AO1
Li, Y1
Khurana, RN1
Nissim, I1
Daniel, E1
Grunwald, J1
Ying, GS1
Pistilli, M1
Maguire, MG1
Dunaief, JL1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effect of Alpha-Lipoic Acid on the Clinical Outcome of Patients With Sepsis[NCT05808946]Phase 2/Phase 360 participants (Anticipated)Interventional2023-03-10Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for thioctic acid and Dry Macular Degeneration

ArticleYear
Orally Administered Alpha Lipoic Acid as a Treatment for Geographic Atrophy: A Randomized Clinical Trial.
    Ophthalmology. Retina, 2020, Volume: 4, Issue:9

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antioxidants; Dose-Response Relationship, Drug; Doubl

2020